2016
DOI: 10.1016/j.biopha.2016.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Protein regulator of cytokinesis 1 overexpression predicts biochemical recurrence in men with prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
18
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 18 publications
1
18
0
Order By: Relevance
“…For example, the study of Wang et al has revealed that lncRNA HCP5 may promote the malignant behavior of ovarian cancer cells by miR-525-5p/PRC1 crosstalk and Wnt/β-catenin pathway [60]. PRC1 has been associated with many malignant carcinomas, such as NPC [61], prostate cancer [62], and lung cancer [63]. In vitro experiments have shown that PRC1 depletion inhibits the multiplication and invasiveness of NPC, while in vivo studies have found that PRC1 inhibits the neoplasia and radioresistance of NPC [61].…”
Section: Discussionmentioning
confidence: 99%
“…For example, the study of Wang et al has revealed that lncRNA HCP5 may promote the malignant behavior of ovarian cancer cells by miR-525-5p/PRC1 crosstalk and Wnt/β-catenin pathway [60]. PRC1 has been associated with many malignant carcinomas, such as NPC [61], prostate cancer [62], and lung cancer [63]. In vitro experiments have shown that PRC1 depletion inhibits the multiplication and invasiveness of NPC, while in vivo studies have found that PRC1 inhibits the neoplasia and radioresistance of NPC [61].…”
Section: Discussionmentioning
confidence: 99%
“…Numbers studies have reported the role of PRC1 in cancer development. Luo et al found that PRC1 expression levels were significantly higher in prostate cancer (PCa) tissues than those in normal tissues; in addition, overexpression of PRC1 was significantly associated with advanced clinicopathologic features and a shorter biochemical recurrence-free survival in patients with PCa [ 29 ]. Bu et al observed that the mRNA and protein expression levels were up-regulated in high-grade serous ovarian carcinoma (HGSOC) tissues, and knockdown of PRC1 could reduce the proliferation, metastasis, and in vitro multidrug resistance of ovarian cancer cell [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…The deregulation of PRC1 contributes to tumorigenesis and cancer process [ 14 , 15 ]. A recent study confirmed that the dysregulation of PRC1 might be responsible for biochemical recurrence in patients with prostate cancer, implying that PRC1 could be considered as a prognostic indicator [ 16 ]. Consistently, a previous report revealed PRC1 was accumulated in the breast cancer, and PRC1 promoter exhibited cancer-specific activity [ 17 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, PRC1 levels signi cantly decrease after cells exit mitosis and enter G1, and are high during the S and G2/M stages [58]. PRC1 has been associated with many malignant carcinomas, such as NPC [59], prostate cancer [60], and lung cancer [61]. In vitro experiments have shown that PRC1 depletion inhibits the multiplication and invasiveness of NPC, while in vivo studies have found that PRC1 inhibits the neoplasia and radioresistance of NPC [59].…”
Section: Discussionmentioning
confidence: 99%